Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype: The Phase 3 MELATORCH Randomized Clinical Trial.
Sheng X, Huang G, Fang M, Li K, Wu D, Zhang X, Chen J, Zhu D, Chen Y, Li H, Gao Q, Wu L, Tang B, Yan X, Zeng R, Li J, Yu W, Xu J, Hao Y, Jin C, Zou J, Guo J.
Sheng X, et al. Among authors: tang b.
JAMA Oncol. 2026 Jan 2. doi: 10.1001/jamaoncol.2025.5751. Online ahead of print.
JAMA Oncol. 2026.
PMID: 41481311